SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Herthelius Maria))
 

Search: (WFRF:(Herthelius Maria)) > (2015-2019) > Management of BK-vi...

Management of BK-virus infection - Swedish recommendations

Dalianis, Tina (author)
Karolinska Institutet
Eriksson, Britt-Marie, Docent, 1952- (author)
Uppsala universitet,Infektionssjukdomar
Felldin, Marie (author)
Sahlgrens Univ Hosp, Transplant Inst, Gothenburg, Sweden
show more...
Friman, Vanda, 1952 (author)
Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden
Hammarin, Anna-Lena (author)
Unit Lab Dev & Technol Transfer, Publ Hlth Agcy Sweden, Stockholm, Sweden
Herthelius, Maria (author)
Karolinska Institutet
Ljungmang, Per (author)
Karolinska Univ Hosp, Dept Cellular Therapy & Allogene Stem Cell Transp, Stockholm, Sweden
Mölne, Johan, 1958 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för laboratoriemedicin,Department of Laboratory Medicine
Wennberg, Lars (author)
Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden;Karolinska Univ Hosp, Dept Transplantat Surg, Stockholm, Sweden
Swartling, Lisa (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2019-04-23
2019
English.
In: Infectious Diseases. - : TAYLOR & FRANCIS LTD. - 2374-4235 .- 2374-4243. ; 51:7, s. 479-484
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • BK-virus (BKV) associated nephropathy (BKVAN) and BKV associated haemorrhagic cystitis (HC) are complications of BKV infection/reactivation in renal and allogeneic haematopoietic stem cell transplantation (HSCT) patients, respectively. The task of how to manage these diseases was given to the chair by the Swedish Reference Group for Antiviral Therapy (RAV). After individual contributions by members of the working group, consensus discussions were held in a meeting on 23 January 2018 arranged by RAV. Thereafter, the recommendations were published in Swedish on November 2018. The current translation to English has been approved by all co-authors. High BKV serum levels suggest an increased risk for BKVAN and potential graft failure. For detection of BKVAN, careful monitoring of BKV DNA levels in serum or plasma is recommended the first year after renal transplantation and when increased creatinine serum levels of unknown cause are observed. Notably, a renal biopsy is mandatory for diagnosis. To reduce the risk for progression of BKVAN, there is no specific treatment, and tailored individual decrease of immunosuppression is recommended. For BKV-HC, BKV monitoring is not recommended, since BK-viruria frequently occurs in HSCT patients and the predictive value of BKV in plasma/serum has not been determined. However, the risk for BKV-HC is higher for patients undergoing myeloablative conditioning, having an unrelated, HLA-mismatched, or a cord blood donor, and awareness of the increased risk and early intervention may benefit the patients. Also for BKV-HC, no specific therapy is available. Symptomatic treatment, e.g. forced diuresis and analgesics could be of use.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Keyword

BKV
transplantation
immunosuppression
haemorrhagic cystitis
BKVAN
management
BKV; BKVAN
haemorrhagic cystitis
immunosuppression
management
transplantation

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view